Featured Attorney

Caitlyn E. Kretzschmar

Associate

Caitlyn E. Kretzschmar practices in the Firm’s Complex Litigation, Government Contracts, Insurance, Pharmaceutical Products, and Toxic Torts & Products Liability groups. She has extensive experience with complex contractual disputes and evaluating complex agreements, which includes advising government contractors on government contract rights and obligations and requirements under the Federal Acquisition Regulation and the Defense Federal Acquisition Regulation Supplement. Read More >

Search Hollingsworth LLP's opinions from across the country. >

Precedents

• The Zometa® Cases

  Hollingsworth LLP outwits well-funded plaintiffs' attorney group by prevailing in early trials (including plaintiffs' trial picks) in consolidated litigation for client Novartis Pharmaceuticals Corporation.

• The Parlodel® Trilogy

  11th Circuit affirmance in Rider v. Sandoz Pharmaceuticals completes circuit court Daubert sweep in Parlodel® litigation.

• Favorable settlement reached for Norfolk Southern in largest single tort case in South Carolina history

  Avondale Mills, Inc. v. Norfolk Southern Corp., Civ. No. 1:05-2817-MBS (D.S.C. 2008)

• Court dismissed $4B claim brought by the State of New Mexico against Firm client General Electric.

  New Mexico v. Gen. Electric Co., 467 F.3d 1223 (10th Cir. 2006)

• Federal court grants Daubert and summary judgment motions filed by Firm client General Motors in PCB lawsuit.

  Allgood v. General Motors Corp., No. 1:02-cv-1077-DFH-TAB (S.D. Ind. Sept. 18, 2006)

Verdicts & Opinions

• Firm client Monsanto Company secures summary judgment on failure to warn and implied warranty claims in Roundup® product liability lawsuit.

  Terry v. Monsanto Co., No. 7:19-CV-98 (HL), 2021 WL 4473408 (M.D. Ga. Sept. 29, 2021).

• 5th Circuit affirms Firm client Novartis’s summary judgment win in Tegretol® innovator liability case.

  Johnson v. Novartis Pharmaceuticals Corp., No. 20-50462 (5th Cir. Feb. 5, 2021)

• Idaho court dismisses innovator liability claims against Novartis for lack of specific personal jurisdiction.

  Stirling v. Novartis Pharm. Corp., No. CV01-18-4880 (Idaho 4th Jud. Dist., Ada Cty. July 13, 2020)

• Firm secures voluntary dismissal with prejudice for Novartis.

  Coleson v. Novartis Pharm. Corp., No. 3:18-cv-00359, (S.D. Miss. June 29, 2020)

• Texas district court judge rejects innovator claims against Firm client Novartis Pharmaceuticals Corporation.

  Johnson v. Novartis Pharm. Corp., et al., No. 5:19-cv-01087-OLG (May 7, 2020).